57 / 100

Dr. Nazish Badar | Biotechnology | Best Researcher Award

Dr. National Institute of Health Islamabad , Pakistan

Dr. Dr. Nazish Badar holds a Ph.D. in Biotechnology from Quaid-i-Azam University, Islamabad, with significant expertise in public health and virology. Currently serving as a Laboratory Coordinator at the National Institute of Health, Islamabad, Dr. Nazish Badar oversees infrastructure development, procurement, and training for the NIH-CDC Emerging & Re-emerging Respiratory Viruses Surveillance Project. With extensive experience in molecular diagnostics, quality assurance, and public health surveillance, Dr. Nazish Badar has played a pivotal role in strengthening Pakistan’s response to Influenza and SARS CoV-2. Notably, they received the Prime Minister’s Best Performance Award for COVID-19 diagnostic testing and several accolades for scientific presentations.

 

Professional Profiles:

Qualifications🧬

Ph.D. (Biotechnology), Quaid-i-Azam University, Islamabad (2017-2023)
🧫 M. Phil. (Biotechnology), National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad (2002-2004), Quaid-i-Azam University, Islamabad
🏥 M. Sc. (Public Health), Health Services Academy, Islamabad (In progress, 2023)

Experience🔬

Laboratory Coordinator (2021 to Date)
NIH-CDC Emerging & Re-emerging Respiratory Viruses Surveillance Project
Virology Department, Public Health Laboratories Division
National Institute of Health, Islamabad

Strengths for the Award

Extensive Academic Background:Ph.D. in Biotechnology from Quaid-i-Azam University, Islamabad, demonstrating a strong foundation in advanced research and biotechnology.M. Phil. in Biotechnology from the National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad.M.Sc. in Public Health (in progress) from the Health Services Academy, Islamabad, highlighting a commitment to continuous learning and public health.Rich Professional Experience:Current position as Laboratory Coordinator for the NIH-CDC project on emerging and re-emerging respiratory viruses, showcasing leadership and coordination skills.Over a decade of experience as a Molecular Biologist and Technical Officer in various prestigious projects, emphasizing practical expertise in virology and molecular diagnostics.Previous role as a Research Associate at NIBGE, Faisalabad, working on significant projects such as the prevalence of Hepatitis B Virus genotypes.Notable Achievements:First prize in oral presentation at the EMARIS 1st Scientific Meeting, Amman, Jordan, 2017.Third prize in oral presentation at the PAP meeting AFIP, Pakistan, 2018.Prime Minister’s Best Performance Award for COVID-19 diagnostics, underscoring exceptional contributions during the pandemic.Project Management and Coordination:Experience coordinating infrastructure, personnel, procurement, and establishment of national integrated public health laboratory networks.Proven track record in organizing and providing training courses at provincial and national levels.Expertise in planning, supervising, and performing molecular diagnostic assays and serological techniques.Technical Expertise:Proficiency in molecular diagnostics (PCR, sequencing), serology, and the development of standard operating procedures.Experience with quality assurance, bio-safety, and external quality control panels from WHO and CDC.Publication and Proposal Writing:Successful proposal writing for enhancing influenza surveillance networks and response to various infectious diseases.Publications and contributions to international databases like GISAID, Flunet, and EMFLU.

Areas for Improvement

Broadening Research Focus:While the candidate has a strong focus on respiratory viruses and public health, diversifying research into other areas of biotechnology could enhance their overall profile.International Collaborations:Increasing involvement in international collaborative projects and research initiatives could further strengthen their global research presence and impact.Publication Record:Although experienced, a higher number of publications in high-impact journals would further solidify their research credentials.

Conclusion

The candidate’s extensive experience, academic background, and significant contributions to public health, particularly in the context of respiratory virus surveillance and diagnostics, make them a strong contender for the Best Researcher Award. Their leadership in managing national public health laboratory networks, coupled with their technical expertise and notable achievements, highlight their dedication and excellence in the field. By addressing areas for improvement, such as broadening their research focus and enhancing international collaborations, the candidate can further elevate their research impact and recognition. Overall, their qualifications and accomplishments demonstrate that they are highly deserving of the Best Researcher Award.

✍️Publications Top Note :

📄 External Quality Assessment Program for SARS-CoV-2 Molecular Detection in Pakistan
Authors: Badar, N., Ikram, A., Salman, M., Ashraf, A., Farooq, U.
Influenza and Other Respiratory Viruses, 2024, 18(7), e13316

📄 Evolutionary Analysis of Seasonal Influenza A Viruses in Pakistan 2020–2023
Authors: Badar, N., Ikram, A., Salman, M., Umair, M., Farooq, U.
Influenza and Other Respiratory Viruses, 2024, 18(2), e13262

📄 Estimation of Seasonal Influenza Disease Burden Using Sentinel Site Data in Pakistan 2017–2019: A Cross-sectional Study
Authors: Salman, M., Badar, N., Ikram, A., Nisar, N., Farooq, U.
Influenza and Other Respiratory Viruses, 2023, 17(3), e13125

📄 Prevalence of Human Adenovirus in Pediatric Patients Presenting with Acute Respiratory Symptoms at Different Hospitals of Pakistan
Authors: Ahmad, S., Malik, A., Ullah, I., Muhammad, A., Khan, M.U.
Journal of Ayub Medical College, 2023, 35(1), pp. 37–42

📄 Genomic Diversity of SARS-CoV-2 in Pakistan During the Fourth Wave of Pandemic
Authors: Umair, M., Ikram, A., Rehman, Z., Rana, M.S., Salman, M.
Journal of Medical Virology, 2022, 94(10), pp. 4869–4877

📄 Genomic Surveillance Reveals the Detection of SARS-CoV-2 Delta, Beta, and Gamma VOCs During the Third Wave in Pakistan
Authors: Umair, M., Ikram, A., Salman, M., Rana, M.S., Ali, Q.
Journal of Medical Virology, 2022, 94(3), pp. 1115–1129

📄 Tracking Down B.1.351 SARS-CoV-2 Variant in Pakistan Through Genomic Surveillance
Authors: Umair, M., Ikram, A., Badar, N., Suleman, R., Salman, M.
Journal of Medical Virology, 2022, 94(1), pp. 32–34

📄 Chikungunya Virus: Molecular Epidemiology of Nonstructural Proteins in Pakistan
Authors: Badar, N., Ikram, A., Salman, M., Yasin, M.T., Qazi, J.
PLoS ONE, 2021, 16(12 December), e0260424

📄 Epidemiology of Chikungunya Virus Isolates 2016–2018 in Pakistan
Authors: Badar, N., Ikram, A., Salman, M., Yasin, M.T., Qazi, J.
Journal of Medical Virology, 2021, 93(11), pp. 6124–6131

📄 Genomic Epidemiology of SARS-CoV-2 in Pakistan
Authors: Song, S., Li, C., Kang, L., Xue, Y., Bao, Y.
Genomics, Proteomics and Bioinformatics, 2021, 19(5), pp. 727–740

Nazish Badar | Biotechnology | Best Researcher Award

You May Also Like